The drug maker recorded 48.01% jump in consolidated net profit to Rs 180.45 crore in Q3 FY23 as compared with Rs 121.92 crore in Q3 FY22.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
The drug maker recorded 48.01% jump in consolidated net profit to Rs 180.45 crore in Q3 FY23 as compared with Rs 121.92 crore in Q3 FY22.
| Subscribe To Our Free Newsletter |
